Discover
CNSP
CNS Pharmaceuticals, Inc.
5.98
2 x 4.25
2 x 7.21
bid
ask
+
0.46
8.28%
2 @ 04:00 PM
5.99 +0.01 (0.17%)
| Ytd | 13.90% | |
| 1y | -3.55% |
5.61
day range
5.98
1.90
52 week range
10.59
| Open | 5.62 | Prev Close | 5.52 | Low | 5.61 | High | 5.98 | Mkt Cap | 8.74M |
| Vol | 5.07K | Avg Vol | 11.35K | EPS | -16.66 | P/E | N/A | Forward P/E | -0.28 |
| Beta | 1.05 | Short Ratio | 0.04 | Inst. Own | 0.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 5.19 | 200-d Avg | 4.85 | 1yr Est | 0.50 |
| Income Statement | |||
| Operating Expenses | 2.70M | ||
| Research and Development Expense | 1.20M | ||
| Selling, General and Administrative Expense | 1.50M | ||
| Operating Income | -2.70M | ||
| Interest Expense | 4.00K | ||
| Net Income | -2.59M | ||
| Net Income Common Stock | -2.59M | ||
| Net Income Common Stock (USD) | -2.59M | ||
| Consolidated Income | -2.59M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -2.58M | ||
| Earning Before Interest & Taxes (USD) | -2.58M | ||
| Weighted Average Shares | 6.84M | ||
| Weighted Average Shares Diluted | 6.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.99M | ||
| Cash and Equivalents (USD) | 19.99M | ||
| Current Assets | 21.92M | ||
| Property, Plant & Equipment Net | 15.00K | ||
| Total Assets | 21.94M | ||
| Current Liabilities | 3.74M | ||
| Total Liabilities | 3.74M | ||
| Accumulated Retained Earnings (Deficit) | -107.80M | ||
| Shareholders Equity | 18.20M | ||
| Shareholders Equity (USD) | 18.20M | ||
| Assets Non-Current | 15.00K | ||
| Trade and Non-Trade Payables | 3.74M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.13K | ||
| Net Cash Flow from Financing | 20.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 17.03M | ||
| Capital Expenditure | -3.82K | ||
| Issuance (Purchase) of Equity Shares | 20.71M | ||
| Issuance (Repayment) of Debt Securities | -90.78K | ||
| Net Cash Flow from Investing | -3.82K | ||
| Net Cash Flow from Operations | -3.54M | ||
| Share Based Compensation | 2.44K | ||